Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-260850
Filing Date
2025-10-31
Accepted
2025-10-31 16:30:06
Documents
1
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 13300
  Complete submission text file 0001193125-25-260850.txt   15042
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 440 US-22, SUITE 300 BRIDGEWATER NJ 08807
Business Address
Keenan David Paul (Reporting) CIK: 0002094574 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 251440900